We found that, in adult glioblastoma, patients exhibiting a lack of MTAP expression had better survival than those presenting MTAP expression (median survival of 9.8±0.86 vs. 6.23±0.70 months, respectively, p = 0.00023 in log-rank test) (Figure 4A). This evidence concerns the gene MTAP and glioblastoma.